ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
KEYNOTE-590: Pembrolizumab plus chemotherapy for advanced oesophageal cancer
Prof Ken Kato - National Cancer Center Hospital, Chuo-ku, Japan
Disparities in access to oncology clinical trials across Europe
Prof Ana Carneiro - Lund University, Lund, Sweden
ESMO 2020: Latest updates in prostate cancer
Dr Eleni Efstathiou, Prof Boris Hadaschik, Prof Johann De Bono and Prof Nick Jam...
ASCENT: Sacituzumab govitecan vs treatment of physician’s choice in patients wit...
Dr Aditya Bardia - Massachusetts General Hospital, Boston, USA
ALTA-1L: Brigatinib vs crizotinib for ALK advanced non small cell lung cancer p...
Prof Sanjay Popat - The Royal Marsden Hospital, London, UK
Breast cancer roundup from ESMO 2020
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
OncoAlert and ecancer weekly roundup for September 14-19, 2020
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
IMpassion130: Atezolizumab and nab-paclitaxel in triple-negative breast cancer
Prof Leisha Emens - University of Pittsburgh, Pittsburgh, USA
ATTRACTION-4: Nivolumab plus chemotherapy for gastric or gastroesophageal cancer
Prof Narikazu Boku - National Cancer Center Hospital, Tokyo, Japan
Lenvatinib plus pembrolizumab for advanced melanoma that progressed on a PD-1 or...
Dr Ana Arance - Hospital Clinic Barcelona, Barcelona, Spain
Osimertinib adjuvant therapy in patients with early stage EGFR mutated NSCLC aft...
Dr Masahito Tsuboi - National Cancer Center Hospital, Tokyo, Japan
Latest updates to the ESMO bone health guidelines
Prof Robert Coleman - University of Sheffield, Sheffield, UK